Cite
HARVARD Citation
Romaguera, R. et al. (2022). Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial. European heart journal. pp. 1320-1330. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Romaguera, R. et al. (2022). Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial. European heart journal. pp. 1320-1330. [Online].